Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase II trial of oral vitamin B12 after total gastrectomy for gastric cancer
jRCTs031220328Phase 2Recruiting
- Sponsor
- Advanced Medical Promotion Center
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cyanocobalamin in vitamin B12 deficiency and gastric cancer (GC) (2 arms), sponsored by Advanced Medical Promotion Center. Primary endpoint: Incidence of vitamin B12 levels below 200 pg/mL at 48 weeks. Started Sep 2022; status: recruiting.
02
Drugs
cyanocobalamin
03
Conditions
vitamin B12 deficiencygastric cancer (GC)
Beyond the preview
Go deeper on jRCTs031220328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220328.